Paul's 'A' sample taken out-of-competition on March 18 tested positive for banned substance terbutaline. He was informed of it by the National Anti-Doping Agency on April 24 and given seven days time to make a request for 'B' sample test and that deadline ended yesterday.
"Yes, the footballer has not opted for 'B' sample analysis," NADA Director General Navin Agarwal said.
"The Indian team is playing against Kyrgyzstan next month (June 13 in Bengaluru) in the AFC Asian Cup qualifiers. Subrata wants and hoping that he will be cleared for that match. So, he has filed an appeal to the NADA that his hearing be held as soon as possible," the source said.
Terbutaline, a specified substance, is a bronchodilator and is taken when people have trouble breathing or for medical condition such as asthma. It is also present in commonly-used expectorants administered for cough and cold.
The 30-year-old Paul, an Arjuna Awardee, has said that he has been given treatment for cough which had troubled him on and off recently.
However, he may not get the maximum four-year ban for a first-time dope offender.
There has been six earlier cases of terbutaline doping in India and out them, two have got bans of three months while three have been handed six-month bans. Only one athlete got a ban of one year.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
